Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-28

Clinical Trial Update: To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fasting Conditions [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the relative bioavailability of two fluoxetine capsule brands, Geneva and Dista, in healthy adult males under fasting conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dista (fluoxetine hydrochloride)
  • Geneva (fluoxetine hydrochloride)

Snippet

Sponsor: Sandoz | Conditions: Depression | Phase 1 | Status: COMPLETED